HSV-1 oncolytic virus therapeutic (BullFrog AI)

N/A

Report date: 2024/04/09 16:23:12

Base Information

Drug NameHSV-1 oncolytic virus therapeutic (BullFrog AI)
Drug Alias NameModified HSV-1 therapeutic (BullFrog AI)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsImmunologic cytotoxicity
TargetsUpdating
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBullFrog AI Holdings IncJ. Craig Venter Institute
China Registration ClassN/A

Develop Information

Active CompaniesBullFrog AI Holdings Inc
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A